Gastrointestinal manifestations of non-AIDS immunodeficiency
Tóm tắt
Most primary immunodeficiencies are diagnosed in children and, therefore, are managed by pediatricians and pediatric specialists. Generally, internists and adult gastroenterologists only rarely encounter patients with primary immunodeficiency, and have little or no involvement in actual treatment. However, gastroenterologists should be familiar with primary immunodeficiency because 1) current and future therapy for immunodeficiency will allow more patients to survive into adulthood, 2) some primary immunodeficiencies, particularly common variable immunodeficiency, may have their first clinical manifestation in adolescence or early adulthood, and 3) recently it has been hypothesized that Crohn’s disease may be an immunodeficiency. Detailed treatment recommendations are not included in this review, as subspecialists in pediatrics, immunology, and hematology manage such treatments. Of far greater importance, even in this treatment-oriented forum, is the enhancement of our awareness of these disorders.
Tài liệu tham khảo
Lai Ping So A, Mayer L: Gastrointestinal manifestations of primary immunodeficiency disorders. Sem Gastrointest Dis 1997, 8:22–32. This is an authoritative review of the gastrointestinal manifestations of several immunodeficiencies.
Mamlock RJ: Primary immunodeficiency disorders. Primary Care 1998, 25:739–758.
Dizon JG, Goldberg BJ, Kaplan MS: How to evaluate suspected immunodeficiency. Pediatr Ann 1998, 27:743–750. The evaluation of suspected immunodeficiency is reviewed in detail.
Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999, 118(suppl 1):1–28. The immune system and immunodeficiencies are discussed comprehensively in this review.
Saleem MA, Arkwright PD, Davies EG, et al.: Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child 2000, 83:356–359.
Raz R, Rottem M, Bisharat N, et al.: Intestinal protothecosis in a patient with chronic mucocutaneous candidiasis. Clin Infect Dis 1998, 27:399–400.
Buckley RH: Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000, 343:1313–1324. This is a well-illustrated review of several immunodeficiencies.
Ochs HD: The Wiskott-Aldrich syndrome. Sem Hematol 1998, 35:332–345.
Hwang EH, Oh JT, Han SJ, et al.: Colon perforation in hyperimmunoglobulin E syndrome. J Pediatr Surg 1998, 33:1420–1422.
Spacey SD, Gatti RA, Bebb G: The molecular basis and clinical management of ataxia telangiectasia. Can J Neurol Sci 2000, 27:184–191.
Elder ME: T-cell immunodeficiencies. Pediatr Clin N Am 2000, 47:1253–1274.
Boeck A, Buckley RH, Schiff RI: Gastroesophageal reflux and severe combined immunodeficiency. J Allergy Clin Immunol 1997, 99:420–424.
Strober W, Chua K: Common variable immunodeficiency. Clin Rev Allergy Immunol 2000, 19:157–181. Common variable immunodeficiency and its gastrointestinal manifestations are reviewed.
Hammarstrom L, Vorechovsky I, Webster D: Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000, 120:225–231. A complete review of selective IgA deficiency and CVID, including differential diagnosis.
Verne GN, Amann ST, Cosgrove C, et al.: Chronic diarrhea associated with thymoma and hypogammaglobulinemia (Good’s syndrome). South Med J 1997, 90:444–446.
Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34–48.
Kutukculer N, Yagci RV, Aydogdu S, et al.: Chronic inflammatory bowel disease in a patient with common variable immunodeficiency. Turk J Pediatr 2001, 43:88–90.
Zullo A, Romiti A, Rinaldi V, et al.: Gastric pathology in patients with common variable immunodeficiency. Gut 1999, 45:77–81.
Conley ME, Rohrer J, Minegishi Y: X-linked agammaglobulinemia. Clin Rev Allergy Immunol 2000, 19:183–204.
Cellier C, Foray S, Hermine O: Regional enteritis associated with enterovirus in a patient with X-linked agammaglobulinemia. N Engl J Med 2000, 342:1611–1612.
Lock RJ, Unsworth DJ: Identifying immunoglobulin-A-deficient children and adults does not necessarily help the serologic diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 1999, 28:81–83.
Puck JM: Primary immunodeficiency diseases. JAMA 1997, 278:1835–1841.
Etzioni A, Tonetti M: Leukocyte adhesion deficiency II—from A to almost Z. Immunol Rev 2000, 178:138–147.
Uzel G, Kleiner DE, Kuhns DB, et al.: Dysfunctional LAD-1 neutrophils and colitis. Gastroenterology 2001, 121:958–964. This recent case report, and accompanying editorial, provide a detailed account of this case and speculate on the role of adhesion molecules in inflammatory bowel disease.
Kamani NR, Infante AJ: Chronic granulomatous disease and other disorders of neutrophil function. Clin Rev Allergy Immunol 2000, 19:141–156.
Barton LL, Moussa SL, Villar RG, et al.: Gastrointestinal complications of chronic granulomatous disease: case report and literature review. Clin Pediatr 1998, 37:231–236.
Metin A, Sanal O, Tezcan I, et al.: Gastric antral stricture in a patient with chronic granulomatous disease. Turk J Pediatr 1999, 41:369–373.
Hiller N, Fisher D, Abrahamov A, et al.: Esophageal involvement in chronic granulomatous disease. Case report and review. Pediatr Radiol 1995, 25:308–309.
Korzenik JR, Dieckgraefe BK: Is Crohn’s disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn’s disease. Dig Dis Sci 2000, 45:1121–1129. This article is an engaging, well-referenced argument that Crohn’s disease may be a deficiency of the innate immune system.
Ogura Y, Bonen DK, Inohara N, et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001, 411:603–606.
Hugot JP, Chamaillard M, Zouali H, et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001, 411:599–603.
Elson CO, Cong Y, Sundberg J: The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis. International Rev Immunol 2000, 19:63–75.
Schwartz SA: Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin N Am 2000, 47:1355–1369.
Candotti F: The potential for therapy of immune disorders with gene therapy. Pediatr Clin N Am 2000, 47:1389–1407.
Weinberg KI, Kohn DB: Gene therapy for congenital lymphoid immunodeficiency diseases. Sem Hematol 1998, 35:354–366.
Waldburger JM, Masternak K, Muhlethaler-Mottet A, et al.: Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev 2000, 178:148–165.
Ramesh N, Seki M, Notarangelo LD, et al.: The hyper-IgM (HIM) syndrome. Springer Sem Immunopathol 1998, 19:383–399.
Myrup B, Valerius NH, Mortensen PB: Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998, 42:127–130.
Vaughan D, Drumm B: Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn’s disease. N Engl J Med 1999, 340:239–240.
Korzenik JR, Dieckgraefe BK: Immune stimulation in Crohn’s disease: safety and efficacy of rhuGM-CSF for the treatment of active Crohn’s disease [abstract]. Gastroenterology 2001, 120:A277.
Korzenik JR, Dieckgraefe BK: Immunostimulation in Crohn’s disease: results of a pilot study of G-CSF (R-methug-CSF) in mucosal and fistulizing Crohn’s disease [abstract]. Gastroenterology 2000, 118:A874.